Farnoud Kazemzadeh
Fortuna: 247 $ al 30/09/2026
Fortuna: 247 $ al 30/09/2026
Farnoud Kazemzadeh is the founder of Vital Biosciences, Inc. Currently, Dr. Kazemzadeh is the Chief Operating Officer at Pharmala Biotech Holdings, Inc., starting in 2025.
Dr. Kazemzadeh's education history includes graduate studies at the International Space University and undergraduate, graduate, and doctorate degrees from the University of Waterloo.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/04/2026 | 1.553 ( 0 % ) | 247 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Director de Operaciones | 08/10/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Vital Biosciences, Inc.
Vital Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for detecting and diagnosis dermatological diseases | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
International Space University
International Space University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vital Biosciences, Inc.
Vital Biosciences, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for detecting and diagnosis dermatological diseases | Health Technology |
PharmAla Biotech Holdings, Inc.
PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.